nach oben

Rheumatology International

Erschienen in:

01.01.2012 | Case Report

A sequence of pathologic events in a patient after thymectomy for myasthenia gravis

verfasst von: Antoni Hrycek

Erschienen in: Rheumatology International | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The case of a rare coexistence of myasthenia gravis (MG) with systemic lupus erythematosus (SLE) is described. MG was diagnosed prior to SLE which developed after thymectomy. The patient was affected by HCV viremia. Therefore, there were therapeutic problems. Metylase treatment was continued for several years and dopamine receptor agonist was effectively administered as adjunctive therapy in SLE.

McDonagh JE, Isenberg DA (2000) Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 59:230–232PubMedCrossRef

Hrycek A, Siekiera U (2008) Coeliac disease in systemic lupus erythematosus: a case report. Rheumatol Intern 28:491–493CrossRef

Lorber M, Gershwin ME, Shoenfeld Y (1994) The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthr Rheum 24:105–113CrossRef

Hrycek A (2009) Systemic lupus erythematosus and myasthenia gravis. Pol Arch Med Wewn 119:582–584PubMed

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef

Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef

Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430PubMedCrossRef

Hrycek A, Kuśmierz D, Dybała T, Świątkowska L (2007) Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 40:23–30PubMedCrossRef

Park M-J, Kim Y-A, Lee S-S, B-Ch Kim, Kim M-K, Cho K-H (2004) Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports. J Korean Med Sci 119:134–136CrossRef

10.

Iwadate H, Kobayashi H, Shio K, Noguchi E, Watanabe K, Sasajima T, Sekine H, Watanabe H, Ohira H, Obara K, Sato Y (2006) A case of systemic lupus erythematosus complicated by pure red cell aplasia and idiopathic portal hypertension after thymectomy. Med Rheumatol 16:109–112CrossRef

11.

Yang M, Huang L, Liu W, Sheng Z, Xie H, Liao E (2008) Prolactin may be promising therapeutic target for myasthenia gravis: hypothesis and importance. Med Hypotheses 70:1017–1020PubMedCrossRef

12.

Appenzeller S, Veilleux M, Clarke A (2009) Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus. Lupus 9:836–840CrossRef

13.

Téllez-Zenteno JF, Remes-Troche JM, Mimenza-Alvarado A, Garcia-Ramos G, Estanol B, Vega-Boada F (2003) The association of myasthenia gravis and connective tissue diseases. Effect of thymectomy in six cases. Neurologia 18:54–58PubMed

14.

Cieślik P, Hrycek A, Kłuciński P (2008) Vasculopathy and vasculitis in systemic lupus erythematosus. Pol Arch Med Wewn 118:57–62PubMed

15.

Hrycek A, Pochopień-Kenig G, Ścieszka J (2007) Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 40:217–222PubMedCrossRef

Titel: A sequence of pathologic events in a patient after thymectomy for myasthenia gravis
verfasst von: Antoni Hrycek
Publikationsdatum: 01.01.2012
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 1/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-1301-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A sequence of pathologic events in a patient after thymectomy for myasthenia gravis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

Early endoscopy in systemic sclerosis without gastrointestinal symptoms

Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital

DNA damage and its relationship with other oxidative stress parameters in Behcet’s disease

An unusual case of undifferentiated connective tissue disease presenting as cardiac tamponade

Nicotine inhibits tumor necrosis factor-α induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin